| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1159/000123851 |
| P698 | PubMed publication ID | 18544968 |
| P50 | author | Hugues de Thé | Q33103207 |
| Anne Janin | Q60963223 | ||
| Marc Espié | Q99591504 | ||
| Philippe Bertheau | Q115606211 | ||
| Louis-François Plassa | Q115606219 | ||
| Mariana Varna | Q115606241 | ||
| P2093 | author name string | Elisabeth Turpin | |
| Jacqueline Lehmann | |||
| P2860 | cites work | Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database | Q29616468 |
| P433 | issue | 2 | |
| P921 | main subject | breast cancer | Q128581 |
| chemotherapy | Q974135 | ||
| P304 | page(s) | 132-139 | |
| P577 | publication date | 2008-06-10 | |
| P1433 | published in | Pathobiology | Q2948036 |
| P1476 | title | TP53 status and response to chemotherapy in breast cancer | |
| P478 | volume | 75 |
| Q39087778 | AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53. |
| Q57053007 | Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment |
| Q33903965 | Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance |
| Q33627208 | Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients |
| Q58805589 | Control of metabolism by p53 - Cancer and beyond |
| Q42511112 | Distinct tumor protein p53 mutants in breast cancer subgroups |
| Q39071032 | ETV1 positively regulates transcription of tumor suppressor ARF. |
| Q34825969 | Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer |
| Q55278765 | Expression and Clinical Significance of Claudin-7, PDL-1, PTEN, c-Kit, c-Met, c-Myc, ALK, CK5/6, CK17, p53, EGFR, Ki67, p63 in Triple-negative Breast Cancer-A Single Centre Prospective Observational Study. |
| Q37361137 | Expression profiling of ion channel genes predicts clinical outcome in breast cancer |
| Q42949718 | Igf-Ii Mrna Expression in Breast Cancer: Predictive Value and Relationship to Other Prognostic Factors |
| Q42477466 | Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer |
| Q48875498 | Inhibition of Polo-like kinase 1 prevents the growth of metastatic breast cancer cells in the brain |
| Q39505296 | Inhibition of p53 expression by peptide-conjugated phosphorodiamidate morpholino oligomers sensitizes human cancer cells to chemotherapeutic drugs. |
| Q91677426 | Irradiation induces p53 loss of heterozygosity in breast cancer expressing mutant p53 |
| Q36375382 | Long-term maintenance of prognostic value of survivin and its relationship with p53 in T4 breast cancer patients |
| Q37298047 | Metabolic regulation by p53 family members. |
| Q37845740 | Metabolic regulation by p53. |
| Q38061832 | NRF2 and p53: Januses in cancer? |
| Q35568870 | Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells |
| Q37421781 | Polymorphic variants in TSC1 and TSC2 and their association with breast cancer phenotypes |
| Q35237197 | Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer |
| Q42927985 | Proteomic analysis of regenerating mouse liver following 50% partial hepatectomy |
| Q53686273 | Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer. |
| Q36474056 | Rational Manual and Automated Scoring Thresholds for the Immunohistochemical Detection of TP53 Missense Mutations in Human Breast Carcinomas |
| Q35099531 | Recent advances in p53 research and cancer treatment |
| Q24297440 | Regulation of p53 stability and function by the deubiquitinating enzyme USP42 |
| Q39456823 | SASP: Tumor Suppressor or Promoter? Yes! |
| Q39677335 | SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis. |
| Q89727347 | TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines |
| Q33685392 | TP53 mutations in human cancers: origins, consequences, and clinical use |
| Q35043933 | TP53 status and response to treatment in breast cancers |
| Q24298743 | The RNA helicase p68 modulates expression and function of the Δ133 isoform(s) of p53, and is inversely associated with Δ133p53 expression in breast cancer |
| Q55509868 | The Roles of p53 in Mitochondrial Dynamics and Cancer Metabolism: The Pendulum between Survival and Death in Breast Cancer? |
| Q38074014 | The mutant p53 mouse as a pre-clinical model |
| Q27690770 | The p53 pathway as a target in cancer therapeutics: obstacles and promise |
| Q37906909 | Transcriptional modulation induced by ionizing radiation: p53 remains a central player |
| Q34324683 | Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions |
| Q36083098 | Tumour suppressor genes in chemotherapeutic drug response |
| Q33820871 | Upregulation of Coxsackie Adenovirus Receptor Sensitizes Cisplatin-Resistant Lung Cancer Cells to CRAd-Induced Inhibition |
| Q84310394 | p53 Binds to estrogen receptor 1 promoter in human breast cancer cells |
| Q34202703 | p53 Isoforms: An Intracellular Microprocessor? |
| Q29617084 | p53 and metabolism |
| Q35029530 | p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients. |
| Q37746471 | p53 regulation of metabolic pathways |
| Q59795397 | p53-mediated adaptation to serine starvation is retained by a common tumour-derived mutant |
| Q27851827 | p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer. |
Search more.